|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
EKCOvsoJvEKbwXJCitQ |
|
ÀÌ ¸§ |
Clint |
³¯ Â¥ |
2018/06/28 |
Á¶ ȸ |
1 |
|
I'd like to apply for this job intrinsa patch spc Rigel Pharmaceuticals Inc. (RIGL) said an investigational drug didn't meet primary endpoints in a Phase II stage study of patients with discoid lupus erythematosus and it won't pursue further studies of the treatment for that indication.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|